Charles A. Gersbach
Duke University(US)Duke Energy (United States)(US)Duke Medical Center(US)Duke University Hospital(US)Applied Genetic Technologies (United States)(US)Genetic Technologies (Australia)(AU)Institute for Gerontological Research(DE)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, RNA Interference and Gene Delivery, Virus-based gene therapy research, Pluripotent Stem Cells Research, CAR-T cell therapy research
Most-Cited Works
- → ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering(2013)3,737 cited
- → Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers(2015)1,839 cited
- → The next generation of CRISPR–Cas technologies and applications(2019)1,458 cited
- → RNA-guided gene activation by CRISPR-Cas9–based transcription factors(2013)1,335 cited
- → In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy(2015)1,124 cited
- → Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements(2015)1,028 cited